The coagulation markers market size is projected to be worth US$ 1.21 billion in 2023. The market is likely to surpass US$ 2.22 billion by 2033 at a CAGR of 6.3% during the forecast period. Growing surgical orthopedic procedures, such as venous thromboembolism (VTE), have resulted in a market increase. According to several studies on preoperative risk assessment, the majority of patients undergoing major orthopedic surgery would be hypercoagulable. The use of coagulation markers in the screening of VTE has proven to be quite successful in detecting coagulation activation.
Other Drivers Propelling the Demand for Coagulation Markers include:
Challenges for Companies /Manufacturers in the Coagulation Markers Market:
Opportunities in the Coagulation Markers Industry:
Latest Trends in the Coagulation Markers Market:
| Attributes | Details |
|---|---|
| Coagulation Markers Market Size (2023) | US$ 1.21 billion |
| Coagulation Markers Market Projected Size (2033) | US$ 2.22 billion |
| Value CAGR (2023 to 2033) | 6.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2012 to 2022, the global coagulation markers market experienced a CAGR of 3.5%, reaching a market size of US$ 1.21 billion in 2023. The increased frequency of coagulation diseases such as DVT, PE, and hemophilia has been a key driver for the coagulation markers industry. Because these illnesses are associated with anomalies in blood coagulation, there is a rising demand for coagulation indicators for diagnostic and monitoring purposes.
Increasing identification and diagnosis of coagulation abnormalities has resulted from increasing awareness of these illnesses, as well as enhanced diagnostic skills. Because healthcare personnel are now better trained to diagnose coagulation abnormalities, coagulation indicators are being used for diagnostic purposes. Early identification and management can enhance patient outcomes, propelling the industry forward.
Future Forecast for Coagulation Markers Industry:
Looking ahead, the global coagulation markers industry is expected to rise at a CAGR of 6.3% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 2.22 billion.
The coagulation markers industry is expected to continue its growth trajectory from 2023 to 2033. Continuous technological improvements, such as the development of innovative assays, point-of-care testing devices, and high-throughput automated analyzers, will fuel market expansion. These developments will increase the sensitivity, accuracy, and efficiency of coagulation marker testing, resulting in improved diagnostic capabilities and simpler processes.
The rise of personalized medicine and tailored therapeutics will drive up demand for coagulation indicators. By analyzing coagulation indicators, healthcare practitioners may personalize treatment strategies based on an individual's unique coagulation profile, improving therapeutic results while reducing the risk of bleeding or thrombotic events.
Coagulation Markers Market:
| Attributes | Coagulation Markers Market |
|---|---|
| CAGR (2023 to 2033) | 6.3% |
| Market Value (2033) | US$ 2.22 billion |
| Opportunity | Coagulation indicators can be used with other diagnostic modalities, such as imaging or genetic testing, to offer a more complete picture of coagulation diseases. Combining several markers and diagnostic techniques can improve diagnosis accuracy, help with treatment decisions, and make patient management easier. |
| Key Trends | Collaboration between researchers, doctors, and regulatory agencies is critical for progressing coagulation marker research and encouraging standardized practices. To increase the reliability and comparability of coagulation marker results, collaborative networks promote data sharing, information exchange, and consensus-building. |
Renal Biomarker Market:
| Attributes | Renal Biomarker Market |
|---|---|
| CAGR (2023 to 2033) | 7.4% |
| Market Value (2033) | US$ 2.8 billion |
| Opportunity | Advancements in molecular diagnostic techniques and early-specific biomarkers of CKD diagnosis to bolster market growth. |
| Key Trends | Omics techniques are gradually becoming acknowledged for their significance in the early diagnosis of CKD, although not being frequently. |
Blood Coagulation Analyzers Market:
| Attributes | Blood Coagulation Analyzers Market |
|---|---|
| CAGR (2023 to 2033) | 6.5% |
| Market Value (2033) | US$ 6.1 billion |
| Opportunity | Rise in cardiovascular diseases with underlying obesity expected to be the most pivotal aspect driving the market. |
| Key Trends | Key manufacturers in the market are introducing innovative analyzers that are tiny and simple to integrate, to be used in variety of medical facilities. |
Principal Consultant
| Country | The United States |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 731.3 million |
| CAGR % 2023 to End of Forecast (2033) | 7.3% |
The coagulation markers industry in the United States is expected to reach a market value of US$ 731.3 million by 2033, expanding at a CAGR of 7.3%. The United States continues to experience rapid growth in market due to increasing prevalence of coagulation disorders. The prevalence of coagulation diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), and other thrombotic illnesses has increased in the United States. As a result, there is a greater need for coagulation indicators for the early identification, diagnosis, and monitoring of these illnesses.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 160.8 million |
| CAGR % 2023 to End of Forecast (2033) | 9.4% |
The coagulation markers industry in the United Kingdom is expected to reach a market value of US$ 160.8 million, expanding at a CAGR of 9.4% during the forecast period. The United Kingdom market is projected to experience growth owing to the rising aging population. The United Kingdom has an ageing population, with an increasing number of older people. Advanced age increases the risk of coagulation diseases such atrial fibrillation, venous thromboembolism, and stroke. Coagulation marker testing is becoming more popular as the population ages in order to determine the risk of thrombotic events and guide anticoagulant medication.
| Country | China |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 276.6 million |
| CAGR % 2023 to End of Forecast (2033) | 9.0% |
The coagulation markers industry in China is anticipated to reach a market value of US$ 276.6 million, moving at a CAGR of 9.0% during the forecast period. The coagulation markers industry in China is expected to grow prominently due to the increasing research and development. The long-term socioeconomic growth of China is being centered on scientific and technical innovation, which the Chinese government is promoting through financing, reform, and societal prestige. China's 14th five-year plan (2021-2025) is focused on pursuing innovation-driven growth and aims for research and development investment to expand by more than 7% annually over that time.
The top scientific magazine, Nature Index 2020 Annual Tables, reports that China's contribution to worldwide natural science research climbed by 15% in 2020. The country's favorable environment ensures that the advances in research production witnessed in previous years will continue.
| Country | Japan |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 127.3 million |
| CAGR % 2023 to End of Forecast (2033) | 6.6% |
The coagulation markers industry in Japan is estimated to reach a market value of US$ 127.3 million by 2033, thriving at a CAGR of 6.6%. The market in Japan is predicted to grow because of the growing demand for novel therapies. Ongoing research and development activities focusing on the development of novel coagulation markers, enhanced testing procedures, and customized assays for the Japanese population have aided market expansion. Collaborations among pharmaceutical firms, research institutes, and healthcare providers foster innovation and the development of enhanced coagulation marker testing.
| Country | South Korea |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 74.1 million |
| CAGR % 2023 to End of Forecast (2033) | 5.9% |
The coagulation markers industry in South Korea is expected to reach a market value of US$ 74.1 million, expanding at a CAGR of 5.9% during the forecast period. The market in South Korea is forecasted to witness growth due to the high healthcare expenditure. South Korea spends a lot on healthcare, and the investment in diagnostics and laboratory testing is growing. Coagulation marker tests are an essential aspect of diagnosing coagulation disorders. Coagulation markers market expansion is further aided by the availability of healthcare insurance coverage and reimbursement policies.
The D-dimer assay is expected to dominate the coagulation markers industry with a CAGR of 5.4% from 2023 to 2033. By-products of blood coagulation and breakdown, such as the D-dimer, can be detected via analysis of a blood sample. D-dimer is produced when a blood clot starts to dissolve. This explains why D-dimer test has a large market share.
When a doctor suspects that anything other than DVT or PE is the cause of the symptoms, D-dimer is extremely helpful. It is an efficient, non-invasive method to assist in ruling out irregular or excessive clotting as the underlying reason.
The plasma is expected to dominate the coagulation markers industry with a CAGR of 6.2% from 2022 to 2033.
Since plasma has a high quantity of fibrinogen, this method of detecting coagulation is frequently used. Along with other procoagulants like thrombin and factor X, fibrinogen is one of the main players in the process of blood clotting. The use of plasma as a specimen for coagulation tests is increasing as a result of this factor.
The ELISA is expected to dominate the coagulation markers industry with a CAGR of 5.4% from 2023 to 2033. The Human Coagulation Factor XII ELISA kit is intended for measuring coagulation factor XII levels in plasma. ELISA kits include recombinant monoclonal antibodies for specific and sensitive findings, as well as a single-wash technique that reduces test time to 90 minutes. The demand for ELISA kits is being driven by the shortened test time and effective outcomes.
Disseminated intravascular coagulation (DIC) is expected to dominate in the application segment with a CAGR of 6.7% from 2023 to 2033. Due to the rising incidence of cancer, it is projected that the market for diffused intravascular coagulation (DIC) would expand quickly over the forecast period. By 2040, the International Agency for Research on Cancer (IARC) projects that there will be 16.3 million cancer-related deaths and 27.5 million new cases worldwide. One of the main causes of disseminated intravascular coagulation (DIC) is cancer. Blood clotting proteins become overactive in a dangerous disorder known as diffused intravascular coagulation (DIC).
By purpose, clinical use segment is expected to continue leading the market over a CAGR of 6.0% throughout the projected timeframe. Coagulation tests have been shown to be clinically useful in the detection of cardiovascular illnesses and coagulation disorders, particularly DVT. Coagulant levels in the circulation increase dramatically in response to various illnesses, making it an important indicator for diagnosis. Because of their diagnostic usefulness, Coagulation tests are now widely used in clinical practice to guide antibiotic treatment and help clinical decision-making.
The hospitals have led the coagulation markers market as the leading end user with the CAGR of 7.4% in 2023 to 2033. Hospitals are the principal providers of acute care, serving a diverse variety of patients, including those suffering from severe chronic illnesses, coagulation problems, and other urgent circumstances. Coagulation tests are extremely useful in these conditions, assisting in the diagnosis, monitoring, and treatment of cardiovascular disorders. In these acute care circumstances, hospitals rely on coagulation tests to assist clinical decision-making, guide antibiotic treatment, and assess patient prognosis.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The coagulation markers industry is highly competitive, with numerous players vying for market share. In such a scenario, key players must adopt effective strategies to stay ahead of the competition.
Key Strategies Adopted by the Players
Companies invest heavily in research and development to deliver novel products that improve efficiency, dependability, and cost-effectiveness. Product innovation allows businesses to differentiate themselves from their competition while also catering to the changing demands of their clients.
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
The coagulation markers sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.
Mergers and acquisitions are frequently used by key players in the coagulation markers business to consolidate their market position, increase their product portfolio, and gain access to new markets.
Key Developments in the Coagulation Markers Market:
China, India, Japan dominate the market in Asia Pacific.
The healthcare sector is the main consumer of coagulation indicators.
The United States is predicted to record a CAGR of 5% from 2023 to 2033.
The global coagulation markers market was valued at US$ 1.21 billion in 2023
The global coagulation markers market is projected to reach US$ 2.22 billion by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption/ Usage Analysis 4.2. Product USPs/ Features 4.3. Technological Roadmap 4.4. Regulatory Landscape 4.5. PESTEL Analysis 4.6. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Reimbursements Policies 5.2.3. Prevalence of Coagulation Disorders 5.2.4. Increasing Preference for Better Diagnostic And Monitoring Technologies 5.2.5. Frequency of Product Approvals 5.2.6. Strategic Collaborations Among Players 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033 6.1. Historical Volume (in Units) Analysis, 2012 to 2022 6.2. Current and Future Volume (in Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) and Volume (Units) Analysis, 2012 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2012 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033 9.3.1. D-dimer Assay 9.3.2. Fibrinogen Assay 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2012 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033 10.3.1. Plasma 10.3.2. Whole Blood Sample 10.3.3. Other 10.4. Market Attractiveness Analysis By Sample Type 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Technology 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Technology, 2012 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technology, 2023 to 2033 11.3.1. Fluorescence Immunoassay 11.3.2. ELISA 11.3.3. Rapid Test 11.3.4. Particle-enhanced Immunoturbidimetric Assay 11.4. Market Attractiveness Analysis By Technology 12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By Application, 2012 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 12.3.1. Deep Venous Thrombosis (DVT) 12.3.2. Pulmonary Embolism (PE) 12.3.3. Disseminated Intravascular Coagulation (DIC) 12.3.4. Trauma 12.3.5. Others 12.4. Market Attractiveness Analysis By Application 13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Purpose 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Million) Analysis By Purpose, 2012 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Purpose, 2023 to 2033 13.3.1. Clinical Use 13.3.2. Research Use Only 13.4. Market Attractiveness Analysis By Purpose 14. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 14.3.1. Hospital 14.3.2. Specialty Clinics 14.3.3. Academic and Research Institutes 14.3.4. Diagnostics Laboratories 14.4. Market Attractiveness Analysis By End User 15. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2012 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033 15.3.1. North America 15.3.2. Latin America 15.3.3. Europe 15.3.4. South Asia 15.3.5. East Asia 15.3.6. Oceania 15.3.7. Middle East and Africa (Middle East & Africa) 15.4. Market Attractiveness Analysis By Region 16. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. USA 16.3.1.2. Canada 16.3.2. By Product 16.3.3. By Sample Type 16.3.4. By Technology 16.3.5. By Application 16.3.6. By Purpose 16.3.7. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Sample Type 16.4.4. By Technology 16.4.5. By Application 16.4.6. By Purpose 16.4.7. By End User 16.5. Country Level Analysis & Forecast 16.5.1. USA Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Sample Type 16.5.1.2.3. By Technology 16.5.1.2.4. By Application 16.5.1.2.5. By Purpose 16.5.1.2.6. By End User 16.5.2. Canada Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Sample Type 16.5.2.2.3. By Technology 16.5.2.2.4. By Application 16.5.2.2.5. By Purpose 16.5.2.2.6. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. Brazil 17.3.1.2. Mexico 17.3.1.3. Argentina 17.3.1.4. Rest of Latin America 17.3.2. By Product 17.3.3. By Sample Type 17.3.4. By Technology 17.3.5. By Application 17.3.6. By Purpose 17.3.7. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Sample Type 17.4.4. By Technology 17.4.5. By Application 17.4.6. By Purpose 17.4.7. By End User 17.5. Country Level Analysis & Forecast 17.5.1. Brazil Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Sample Type 17.5.1.2.3. By Technology 17.5.1.2.4. By Application 17.5.1.2.5. By Purpose 17.5.1.2.6. By End User 17.5.2. Mexico Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Sample Type 17.5.2.2.3. By Technology 17.5.2.2.4. By Application 17.5.2.2.5. By Purpose 17.5.2.2.6. By End User 17.5.3. Argentina Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Sample Type 17.5.3.2.3. By Technology 17.5.3.2.4. By Application 17.5.3.2.5. By Purpose 17.5.3.2.6. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. Germany 18.3.1.2. France 18.3.1.3. Italy 18.3.1.4. UK 18.3.1.5. Spain 18.3.1.6. Russia 18.3.1.7. BENELUX 18.3.1.8. Rest of Europe 18.3.2. By Product 18.3.3. By Sample Type 18.3.4. By Technology 18.3.5. By Application 18.3.6. By Purpose 18.3.7. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Sample Type 18.4.4. By Technology 18.4.5. By Application 18.4.6. By Purpose 18.4.7. By End User 18.5. Country Level Analysis & Forecast 18.5.1. Germany Market Analysis 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Sample Type 18.5.1.2.3. By Technology 18.5.1.2.4. By Application 18.5.1.2.5. By Purpose 18.5.1.2.6. By End User 18.5.2. France Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Sample Type 18.5.2.2.3. By Technology 18.5.2.2.4. By Application 18.5.2.2.5. By Purpose 18.5.2.2.6. By End User 18.5.3. Italy Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product 18.5.3.2.2. By Sample Type By Technology 18.5.3.2.3. By Application 18.5.3.2.4. By Purpose 18.5.3.2.5. By End User 18.5.4. UK Market Analysis 18.5.4.1. Introduction 18.5.4.2. Market Analysis and Forecast by Market Taxonomy 18.5.4.2.1. By Product 18.5.4.2.2. By Sample Type 18.5.4.2.3. By Technology 18.5.4.2.4. By Application 18.5.4.2.5. By Purpose 18.5.4.2.6. By End User 18.5.5. Spain Market Analysis 18.5.5.1. Introduction 18.5.5.2. Market Analysis and Forecast by Market Taxonomy 18.5.5.2.1. By Product 18.5.5.2.2. By Sample Type 18.5.5.2.3. By Technology 18.5.5.2.4. By Application 18.5.5.2.5. By Purpose 18.5.5.2.6. By End User 18.5.6. Russia Market Analysis 18.5.6.1. Introduction 18.5.6.2. Market Analysis and Forecast by Market Taxonomy 18.5.6.2.1. By Product 18.5.6.2.2. By Sample Type 18.5.6.2.3. By Technology 18.5.6.2.4. By Application 18.5.6.2.5. By Purpose 18.5.6.2.6. By End User 18.5.7. BENELUX Market Analysis 18.5.7.1. Introduction 18.5.7.2. Market Analysis and Forecast by Market Taxonomy 18.5.7.2.1. By Product 18.5.7.2.2. By Sample Type 18.5.7.2.3. By Technology 18.5.7.2.4. By Application 18.5.7.2.5. By Purpose 18.5.7.2.6. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. India 19.3.1.2. Thailand 19.3.1.3. Indonesia 19.3.1.4. Malaysia 19.3.1.5. Rest of South Asia 19.3.2. By Product 19.3.3. By Sample Type 19.3.4. By Technology 19.3.5. By Application 19.3.6. By Purpose 19.3.7. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Sample Type 19.4.4. By Technology 19.4.5. By Application 19.4.6. By Purpose 19.4.7. By End User 19.5. Country Level Analysis & Forecast 19.5.1. India Market Analysis 19.5.1.1. Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Sample Type 19.5.1.2.3. By Technology 19.5.1.2.4. By Application 19.5.1.2.5. By Purpose 19.5.1.2.6. By End User 19.5.2. Thailand Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Sample Type 19.5.2.2.3. By Technology 19.5.2.2.4. By Application 19.5.2.2.5. By Purpose 19.5.2.2.6. By End User 19.5.3. Indonesia Market Analysis 19.5.3.1. Introduction 19.5.3.2. Market Analysis and Forecast by Market Taxonomy 19.5.3.2.1. By Product 19.5.3.2.2. By Sample Type 19.5.3.2.3. By Technology 19.5.3.2.4. By Application 19.5.3.2.5. By Purpose 19.5.3.2.6. By End User 19.5.4. Malaysia Market Analysis 19.5.4.1. Introduction 19.5.4.2. Market Analysis and Forecast by Market Taxonomy 19.5.4.2.1. By Product 19.5.4.2.2. By Sample Type 19.5.4.2.3. By Technology 19.5.4.2.4. By Application 19.5.4.2.5. By Purpose 19.5.4.2.6. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. China 20.3.1.2. Japan 20.3.1.3. South Korea 20.3.2. By Product 20.3.3. By Sample Type 20.3.4. By Technology 20.3.5. By Application 20.3.6. By Purpose 20.3.7. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Sample Type 20.4.4. By Technology 20.4.5. By Application 20.4.6. By Purpose 20.4.7. By End User 20.5. Country Level Analysis & Forecast 20.5.1. China Market Analysis 20.5.1.1. Introduction 20.5.1.2. Market Analysis and Forecast by Market Taxonomy 20.5.1.2.1. By Product 20.5.1.2.2. By Sample Type 20.5.1.2.3. By Technology 20.5.1.2.4. By Application 20.5.1.2.5. By Purpose 20.5.1.2.6. By End User 20.5.2. Japan Market Analysis 20.5.2.1. Introduction 20.5.2.2. Market Analysis and Forecast by Market Taxonomy 20.5.2.2.1. By Product 20.5.2.2.2. By Sample Type 20.5.2.2.3. By Technology 20.5.2.2.4. By Application 20.5.2.2.5. By Purpose 20.5.2.2.6. By End User 20.5.3. South Korea Market Analysis 20.5.3.1. Introduction 20.5.3.2. Market Analysis and Forecast by Market Taxonomy 20.5.3.2.1. By Product 20.5.3.2.2. By Sample Type 20.5.3.2.3. By Technology 20.5.3.2.4. By Application 20.5.3.2.5. By Purpose 20.5.3.2.6. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 21.1. Introduction 21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 21.3.1. By Country 21.3.1.1. Australia 21.3.1.2. New Zealand 21.3.2. By Product 21.3.3. By Sample Type 21.3.4. By Technology 21.3.5. By Application 21.3.6. By Purpose 21.3.7. By End User 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Product 21.4.3. By Sample Type 21.4.4. By Technology 21.4.5. By Application 21.4.6. By Purpose 21.4.7. By End User 21.5. Country Level Analysis & Forecast 21.5.1. Australia Market Analysis 21.5.1.1. Introduction 21.5.1.2. Market Analysis and Forecast by Market Taxonomy 21.5.1.2.1. By Product 21.5.1.2.2. By Sample Type 21.5.1.2.3. By Technology 21.5.1.2.4. By Application 21.5.1.2.5. By Purpose 21.5.1.2.6. By End User 21.5.2. New Zealand Market Analysis 21.5.2.1. Introduction 21.5.2.2. Market Analysis and Forecast by Market Taxonomy 21.5.2.2.1. By Product 21.5.2.2.2. By Sample Type 21.5.2.2.3. By Technology 21.5.2.2.4. By Application 21.5.2.2.5. By Purpose 21.5.2.2.6. By End User 21.6. Market Trends 21.7. Key Market Participants - Intensity Mapping 21.8. Drivers and Restraints - Impact Analysis 22. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033 22.1. Introduction 22.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 22.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 22.3.1. By Country 22.3.1.1. GCC Countries 22.3.1.2. Türkiye 22.3.1.3. Northern Africa 22.3.1.4. South Africa 22.3.1.5. Rest of Middle East and Africa 22.3.2. By Product 22.3.3. By Sample Type 22.3.4. By Technology 22.3.5. By Application 22.3.6. By Purpose 22.3.7. By End User 22.4. Market Attractiveness Analysis 22.4.1. By Country 22.4.2. By Product 22.4.3. By Sample Type 22.4.4. By Technology 22.4.5. By Application 22.4.6. By Purpose 22.4.7. By End User 22.5. Country Level Analysis & Forecast 22.5.1. GCC Countries Market Analysis 22.5.1.1. Introduction 22.5.1.2. Market Analysis and Forecast by Market Taxonomy 22.5.1.2.1. By Product 22.5.1.2.2. By Sample Type 22.5.1.2.3. By Technology 22.5.1.2.4. By Application 22.5.1.2.5. By Purpose 22.5.1.2.6. By End User 22.5.2. Türkiye Market Analysis 22.5.2.1. Introduction 22.5.2.2. Market Analysis and Forecast by Market Taxonomy 22.5.2.2.1. By Product 22.5.2.2.2. By Sample Type 22.5.2.2.3. By Technology 22.5.2.2.4. By Application 22.5.2.2.5. By Purpose 22.5.2.2.6. By End User 22.5.3. Northern Africa Market Analysis 22.5.3.1. Introduction 22.5.3.2. Market Analysis and Forecast by Market Taxonomy 22.5.3.2.1. By Product 22.5.3.2.2. By Sample Type 22.5.3.2.3. By Technology 22.5.3.2.4. By Application 22.5.3.2.5. By Purpose 22.5.3.2.6. By End User 22.5.4. South Africa Market Analysis 22.5.4.1. Introduction 22.5.4.2. Market Analysis and Forecast by Market Taxonomy 22.5.4.2.1. By Product 22.5.4.2.2. By Sample Type 22.5.4.2.3. By Technology 22.5.4.2.4. By Application 22.5.4.2.5. By Purpose 22.5.4.2.6. By End User 22.6. Market Trends 22.7. Key Market Participants - Intensity Mapping 22.8. Drivers and Restraints - Impact Analysis 23. Market Structure Analysis 23.1. Market Analysis by Tier of Companies 23.2. Market Share Analysis of Top Players 23.3. Market Presence Analysis 24. Competition Analysis 24.1. Competition Dashboard 24.2. Branding and Promotional Strategies, By Key Players 24.3. Key Development Analysis 24.4. Competition Deep Dive 24.4.1. Accuquik Test Kits 24.4.1.1. Overview 24.4.1.2. Product Portfolio 24.4.1.3. Key Financials 24.4.1.4. Sales Footprint 24.4.1.5. SWOT Analysis 24.4.1.6. Strategy Overview 24.4.1.6.1. Marketing Strategy 24.4.1.6.2. Product Strategy 24.4.1.6.3. Channel Strategy 24.4.2. CTK Biotech, Inc. 24.4.2.1. Overview 24.4.2.2. Product Portfolio 24.4.2.3. Key Financials 24.4.2.4. Sales Footprint 24.4.2.5. SWOT Analysis 24.4.2.6. Strategy Overview 24.4.2.6.1. Marketing Strategy 24.4.2.6.2. Product Strategy 24.4.2.6.3. Channel Strategy 24.4.3. Siemens Healthcare Private Limited 24.4.3.1. Overview 24.4.3.2. Product Portfolio 24.4.3.3. Key Financials 24.4.3.4. Sales Footprint 24.4.3.5. SWOT Analysis 24.4.3.6. Strategy Overview 24.4.3.6.1. Marketing Strategy 24.4.3.6.2. Product Strategy 24.4.3.6.3. Channel Strategy 24.4.4. Quidel Corporation 24.4.4.1. Overview 24.4.4.2. Product Portfolio 24.4.4.3. Key Financials 24.4.4.4. Sales Footprint 24.4.4.5. SWOT Analysis 24.4.4.6. Strategy Overview 24.4.4.6.1. Marketing Strategy 24.4.4.6.2. Product Strategy 24.4.4.6.3. Channel Strategy 24.4.5. Eurolyser Diagnostica GmbH 24.4.5.1. Overview 24.4.5.2. Product Portfolio 24.4.5.3. Key Financials 24.4.5.4. Sales Footprint 24.4.5.5. SWOT Analysis 24.4.5.6. Strategy Overview 24.4.5.6.1. Marketing Strategy 24.4.5.6.2. Product Strategy 24.4.5.6.3. Channel Strategy 24.4.6. Goldsite Diagnostics Inc 24.4.6.1. Overview 24.4.6.2. Product Portfolio 24.4.6.3. Key Financials 24.4.6.4. Sales Footprint 24.4.6.5. SWOT Analysis 24.4.6.6. Strategy Overview 24.4.6.6.1. Marketing Strategy 24.4.6.6.2. Product Strategy 24.4.6.6.3. Channel Strategy 24.4.7. Diazyme Laboratories, Inc 24.4.7.1. Overview 24.4.7.2. Product Portfolio 24.4.7.3. Key Financials 24.4.7.4. Sales Footprint 24.4.7.5. SWOT Analysis 24.4.7.6. Strategy Overview 24.4.7.6.1. Marketing Strategy 24.4.7.6.2. Product Strategy 24.4.7.6.3. Channel Strategy 24.4.8. Hipro Biotechnology Co.,Ltd. 24.4.8.1. Overview 24.4.8.2. Product Portfolio 24.4.8.3. Key Financials 24.4.8.4. Sales Footprint 24.4.8.5. SWOT Analysis 24.4.8.6. Strategy Overview 24.4.8.6.1. Marketing Strategy 24.4.8.6.2. Product Strategy 24.4.8.6.3. Channel Strategy 25. Assumptions and Acronyms Used 26. Research Methodology
Explore Healthcare Insights
View Reports
Coagulation Markers Market
